Metabolic vs. hedonic obesity: a conceptual distinction and its clinical implications von Yu, Y‐H, Vasselli, J. R, Zhang, Y, Mechanick, J. I, Korner, J, Peterli, R

Volltext

Weight-sparing effect of insulin detemir: a consequence of central nervous system-mediated reduced energy intake? von Russell-Jones, D., Danne, T., Hermansen, K., Niswender, K., Robertson, K., Thalange, N., Vasselli, J. R., Yildiz, B., Häring, H. U.

Volltext

Garcinia cambogia (Hydroxycitric Acid) as a Potential Antiobesity Agent: A Randomized Controlled Trial von Heymsfield, Steven B, Allison, David B, Vasselli, Joseph R, Pietrobelli, Angelo, Greenfield, Debra, Nunez, Christopher

Volltext

Characterization system for research on energy storage capacitors von Noriega, J. R., Iyore, O. D., Budime, C., Gnade, B., Vasselli, J.

Volltext

Note: ion source design for ion trap systems von Noriega, J R, Quevedo, M, Gnade, B, Vasselli, J

Volltext

Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distribution von ROSENBAUM, M, PIETROBELLI, A, VASSELLI, J. R, HEYMSFIELD, S. B, LEIBEL, R. L

Volltext

Comparison of neat and photo-crosslinked polyvinylidene fluoride-co-hexafluoropropylene thin film dielectrics formed by spin-coating von Iyore, O.D., Roodenko, K., Winkler, P.S., Noriega, J.R., Vasselli, J.J., Chabal, Y.J., Gnade, B.E.

Volltext

A Phase I Multi-Arm Dose-Expansion Study of the Anti-Programmed Cell Death-Ligand-1 (Pd-L1) Antibody Medi4736: Preliminary Data von Segal, N.H., Hamid, O., Hwu, W., Massard, C., Butler, M., Antonia, S., Blake-Haskins, A., Robbins, P.B., Li, X., Vasselli, J., Khleif, S.

Volltext

464 (PB452): Determination of the phase 2 dose of AU-007, an AI-designed human monoclonal antibody that redirects IL-2 to T-effector cells von Wyant, T., McKean, M., Rasco, D., Haydon, A.M., Powderly, J.D., Weickhardt, A.J., Ahern, E.S., De Souza, P., Ganju, V., Hu-Lieskovan, S., Kichenadasse, G., Tang, J., Richards, L., Knickerbocker, A., Amit, I., Ofran, Y., Vasselli, J.

Volltext

The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma von Maranchie, Jodi K, Vasselli, James R, Riss, Joseph, Bonifacino, Juan S, Linehan, W.Marston, Klausner, Richard D

Volltext

Predicting Survival in Patients with Metastatic Kidney Cancer by Gene-Expression Profiling in the Primary Tumor von Vasselli, James R., Shih, Joanna H., Iyengar, Shuba R., Maranchie, Jodi, Riss, Joseph, Worrell, Robert, Torres-Cabala, Carlos, Tabios, Ray, Mariotti, Andra, Stearman, Robert, Merino, Maria, Walther, McClellan M., Simon, Richard, Klausner, Richard D., Linehan, W. Marston

Volltext

Genetic basis of cancer of the kidney: Disease-specific approaches to therapy von LINEHAN, W. Marston, VASSELLI, James, TORO, Jorge, ZBAR, Berton, BOTTARO, Donald, NECKERS, Len, SRINIVASAN, Ramaprasad, WALTHER, Mcclellan M, MERINO, Maria, CHOYKE, Peter, VOCKE, Cathy, SCHMIDT, Laura, ISAACS, Jennifer S, GLENN, Gladys

Volltext

Clinical Activity and Safety of Medi4736, an Anti-Programmed Cell Death-Ligand 1 (Pd-L1) Antibody, in Patients with Non-Small Cell Lung Cancer von Antonia, S., Ou, S., Khleif, S., Brahmer, J.R., Blake-Haskins, A., Robbins, P.B., Li, X., Vasselli, J., Rizvi, N.

Volltext

1325PCLINICAL ACTIVITY AND SAFETY OF MEDI4736, AN ANTI-PROGRAMMED CELL DEATH-LIGAND 1 (PD-L1) ANTIBODY, IN PATIENTS WITH NON-SMALL CELL LUNG CANCER von Antonia, S., Ou, S., Khleif, S., Brahmer, J.R., Blake-Haskins, A., Robbins, P.B., Li, X., Vasselli, J., Rizvi, N.

Volltext

988PDCLINICAL ACTIVITY AND SAFETY OF MEDI4736, AN ANTI-PD-L1 ANTIBODY, IN PATIENTS WITH HEAD AND NECK CANCER von Fury, M., Ou, S.I., Balmanoukian, A., Hansen, A., Massarelli, E., Blake-Haskins, A., Li, X., Robbins, P.B., Vasselli, J., Segal, N.H.

Volltext

1058PDA PHASE I MULTI-ARM DOSE-EXPANSION STUDY OF THE ANTI-PROGRAMMED CELL DEATH-LIGAND-1 (PD-L1) ANTIBODY MEDI4736: PRELIMINARY DATA von Segal, N.H., Hamid, O., Hwu, W., Massard, C., Butler, M., Antonia, S., Blake-Haskins, A., Robbins, P.B., Li, X., Vasselli, J., Khleif, S.

Volltext

Clinical Activity and Safety of Medi4736, an Anti-Pd-L1 Antibody, in Patients with Head and Neck Cancer von Fury, M., Ou, S.I., Balmanoukian, A., Hansen, A., Massarelli, E., Blake-Haskins, A., Li, X., Robbins, P.B., Vasselli, J., Segal, N.H.

Volltext

Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma von Papadimitrakopoulou, Vasiliki A., Frank, Steven J., Cohen, Ezra W., Hirsch, Fred R., Myers, Jeffrey N., Heymach, John V., Lin, Heather, Tran, Hai T., Chen, Changhu R., Jimeno, Antonio, Nedzi, Lucien, Vasselli, Joseph R., Lowe, Elizabeth S., Raben, David

Volltext

Lack of a functional VHL gene product in renal cell carcinoma cells sensitizes to the apoptotic effects of the protein synthesis inhibitor verrucarin A von Woldemichael, G M, Turbyville, T J, Vasselli, J R, Linehan, WM, McMahon, J B

Volltext

The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells von Koochekpour, S, Jeffers, M, Wang, P H, Gong, C, Taylor, G A, Roessler, L M, Stearman, R, Vasselli, J R, Stetler-Stevenson, W G, Kaelin, Jr, W G, Linehan, W M, Klausner, R D, Gnarra, J R, Vande Woude, G F

Volltext